Kerecis Begins Omega3 Viruxide COVID-19 Trial at the National Hospital of Iceland
Kerecis and the National Hospital of Iceland are conducting a randomized, controlled, double-blind clinical study
Ragna Bjorg April 9, 2020
Menu
Kerecis and the National Hospital of Iceland are conducting a randomized, controlled, double-blind clinical study
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and infection control markets.